United States of America as represented by the Department of Veteran Affairs

Patent Applications and Registrations

Patent applications and USPTO patent grants for United States of America as represented by the Department of Veteran Affairs.The latest application filed is for "serial quantitative pcr assay for detection, species-discrimination and quanitification of leishmania spp. in human samples".

Company Profile

1.22.2

United States of America as represented by the Department of Veteran Affairs - Washington DC
The United States of America as represented by the Department of Veteran Affairs -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Serial quantitative PCR assay for detection, species-discrimination and quantification of Leishmania spp. in human samples Grant 10,883,147 - Wilson , et al. January 5, 2	2021-01-05
Systems, methods, and devices for sensing and providing biofeedback at target axial load Grant 10,849,395 - Aubin , et al. December 1, 2	2020-12-01
Targeting intracellular target-binding determinants with intracellular antibodies Grant 10,683,363 - Weisbart , et al.	2020-06-16
TGF-beta enhancing compositions for cartilage repair and methods related thereto Grant 10,322,125 - Boden , et al.	2019-06-18
Targeting NC.sub.CA-ATP channel for organ protection following ischemic episode Grant 10,166,244 - Simard J	2019-01-01
Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation Grant 9,801,865 - Moran October 31, 2	2017-10-31
Systemic and local ex vivo gene therapy of the skeleton Grant 9,789,162 - Baylink , et al. October 17, 2	2017-10-17
Serial Quantitative Pcr Assay For Detection, Species-discrimination And Quanitification Of Leishmania Spp. In Human Samples App 20170260595 - Wilson; Mary E. ; et al.	2017-09-14
VMAT inhibitory compounds Grant 9,546,151 - Janowsky , et al. January 17, 2	2017-01-17
Compositions and methods for osteogenic gene therapy Grant 9,458,215 - Lau , et al. October 4, 2	2016-10-04
Methods for reducing oxidative stress in a cell with a sulfhydryl protected glutathione prodrug Grant 9,173,917 - Nagasawa , et al. November 3, 2	2015-11-03
Methods for producing an immune response to tuberculosis Grant 8,961,989 - Lewinsohn , et al. February 24, 2	2015-02-24
Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction Grant 8,895,018 - Vandenbark , et al. November 25, 2	2014-11-25
Live attenuated bacterial vaccine to reduce or inhibit carriage and shedding of enterohemorrhagic Escherichia coli in cattle Grant 8,858,930 - Zhu , et al. October 14, 2	2014-10-14
Proteins with repetitive bacterial-Ig-like (Big) domains present in leptospira species Grant 8,802,835 - Ko , et al. August 12, 2	2014-08-12
Methods for treating spinal cord injury with a compound that inhibits a NCCA-ATP channel Grant 8,569,377 - Simard October 29, 2	2013-10-29
Method for isolating nuclei Grant 8,546,134 - Nagata October 1, 2	2013-10-01
Tocopherol Derivatives And Methods Of Use App 20130158106 - Breen; Philip J. ; et al.	2013-06-20
Methods for producing an immune response to tuberculosis Grant 8,440,206 - Lewinsohn , et al. May 14, 2	2013-05-14
Compositions, methods and devices for maintaining an organ Grant 8,409,846 - Hassanein , et al. April 2, 2	2013-04-02
Hydrogel nanocompsites for ophthalmic applications Grant 8,153,156 - Ravi April 10, 2	2012-04-10
Pro-apoptotic bacterial vaccines to enhance cellular immune responses Grant 8,021,671 - Kernodle , et al. September 20, 2	2011-09-20
Therapy for microbial infections Grant 7,173,007 - Zaiou , et al. February 6, 2	2007-02-06
Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen Grant 6,552,006 - Raz , et al. April 22, 2	2003-04-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.